Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Ophthalmic Devices Market Surges to USD 100.2 Billion by 2033, Propelled by 6.4% CAGR
\n \n The Ophthalmic Devices Market is witnessing robust expansion driven by rising demand for advanced eye care solutions, growing prevalence of vision disorders, and a rapidly aging population. Technological advancements such as AI-driven diagnostics, minimally invasive surgical systems, and…
Outlook Therapeutics requests Type A meeting with FDA following second CRL for ONS-5010
(Image Credit: AdobeStock) Outlook Therapeutics has requested a Type A meeting with the US Food and Drug Administration following the agency issuing a complete response letter (CRL) to its biologics license application (BLA) resubmission for ONS-5010 (bevacizumab-vikg) for the treatment…
Treating ophthalmic artery stenosis in geographic atrophy with angioplasty
(Image credit: AdobeStock/Rina) A study that evaluated the safety and feasibility of treating ophthalmic artery stenoses with angioplasty in patients with late-stage age-related macular degeneration (AMD) with geographic atrophy (GA) showed reported observing efficacy and functional improvement in this patient…
The state of retina at ASRS 2025 with Charles C. Wykoff, MD, PhD, and Kevin Quinn
(Image credit: AdobeStock/vetrana) The annual scientific meeting of the American Society of Retina Specialists (ASRS) was held in Long Beach, California from July 30 through August 2, 2025. At this event, researchers and experts in the retina field shared data…
EyeCool Therapeutics appoints Vance Thompson, MD, to board of directors
EyeCool Therapeutics has appointed Vance Thompson, MD, founder of Vance Thompson Vision and immediate past president of the American Society of Cataract and Refractive Surgery (ASCRS), to the company’s board of directors. Thompson has personally performed more than 100,000 vision…
Vicky Demas on the importance of simplifying retinal screenings and incorporating AI
Vicky Demas, PhD, CEO of identifeye HEALTH, spoke to Ophthalmology Times about the company’s recent FDA registration and the it’s innovative retinal imaging technology. The company formally registered with the FDA, enabling them to market their device in the United…
New World Medical launches non-valved glaucoma drainage device, Ahmed ClearPath ST
(Image Credit: AdobeStock) New World Medical has launched Ahmed ClearPath ST, a non-valved glaucoma drainage device. The company stated in a press release that the Ahmed ClearPathST builds on the success of the Ahmed ClearPath by introducing key differences designed to…
Neurotech Pharmaceuticals appoints Peter J. McDonnell, MD, to Board of Directors
Photo of Peter J. McDonnell, MD, provided by Neurotech and used with permission Neurotech Pharmaceuticals, Inc., has appointed had Peter J. McDonnell, MD, to the Board of Directors. McDonnell, along with being a long-time member of the Ophthalmology Times Editorial…
CorNeat Vision's Artificial Cornea Restores Perfect 20/20 Vision in Shingles-Blinded Eye – PR Newswire
CorNeat Vision’s Artificial Cornea Restores Perfect 20/20 Vision in Shingles-Blinded Eye PR Newswire Source: Author: | Date: 2025-09-02 15:14:00 Source: Author: | Date: 2025-09-02 15:14:00
UAlbany freshman hopes to become eye doctor as tribute to mother – MSN
UAlbany freshman hopes to become eye doctor as tribute to mother MSN Source: Author: | Date: 2025-09-02 14:46:00 Source: Author: | Date: 2025-09-02 14:46:00